Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Assist Reprod Genet ; 31(4): 463-9, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24526355

ABSTRACT

OBJECTIVE: Myo-inositol (myoIns) has a positive role in mammalian development and human reproduction. Since experiments on farming species suggest a similar role in preimplantation development, we evaluated the hypothesis that the inclusion of myoIns in human embryo culture media would produce an increase in embryo quality in IVF cycles, using the mouse embryo assay. METHODS: To determine the effect of myoIns on completion of preimplantation development in vitro, one-cell embryos of the inbred C57BL/6N mouse strain were produced by ICSI, cultured in human fertilization media in the presence of myoIns (myoIns+) or in its absence (myoIns-) and evaluated morphologically. Daily progression through cleavage stages, blastocyst production and expansion and blastomere number at 96 hours post fertilization were assessed. RESULTS: Compared to myoIns- embryos, myoIns+ embryos displayed a faster cleavage rate and by the end of preimplantation development, the majority of myoIns+ blastocysts was expanded and formed by a higher number of blastomeres. CONCLUSION: The presence of myoIns resulted in both an increase in proliferation activity and developmental rate of in vitro cultured early mouse embryos, representing a substantial improvement of culture conditions. These data may identify myoIns as an important supplement for human embryo preimplantation culture.


Subject(s)
Blastocyst/drug effects , Embryonic Development/drug effects , Inositol/pharmacology , Animals , Blastocyst/cytology , Cell Proliferation/drug effects , Culture Media , Embryo Culture Techniques , Female , Mice , Mice, Inbred C57BL , Sperm Injections, Intracytoplasmic
2.
Arch Gynecol Obstet ; 288(6): 1405-11, 2013 Dec.
Article in English | MEDLINE | ID: mdl-23708322

ABSTRACT

PURPOSE: The present study aims to investigate the effects of the combined therapy myo-inositol (MI) plus D-chiro-inositol (DCI) or D-chiro-inositol treatment in oocyte quality. METHODS: Polycystic ovary syndrome (PCOS) women undergoing IVF-ET were treated with myo-inositol combined with D-chiro-inositol in the physiological ratio (1.1 g myo-inositol plus 27.6 mg of D-chiro-inositol; INOFOLIC combi Lo.Li.pharma) or D-chiro-inositol alone (500 mg; Interquim, s.a., Barcelona, Spain) to evaluate the umber of morphological mature oocytes, total International Units (IU) of recombinant FSH administered and the number of grade 1 embryos. RESULTS: The data clearly showed that only the combined therapy was able to improve oocyte and embryo quality, as well as pregnancy rates, in PCOS women undergoing IVF-ET. CONCLUSION: The present paper further supports the hypothesis that MI plays a crucial role in the ovary in PCOS women. In particular, due to the physiological role played by MI and DCI, the combined therapy should represent a better choice.


Subject(s)
Fertilization in Vitro , Inositol/therapeutic use , Oocytes/drug effects , Polycystic Ovary Syndrome/drug therapy , Vitamin B Complex/therapeutic use , Adult , Biomarkers/blood , Drug Therapy, Combination , Female , Humans , Inositol/administration & dosage , Oocytes/physiology , Polycystic Ovary Syndrome/blood , Polycystic Ovary Syndrome/complications , Pregnancy , Spain , Treatment Outcome , Vitamin B Complex/administration & dosage
SELECTION OF CITATIONS
SEARCH DETAIL
...